Drug Trial Radar · NCT05566795
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
Last checked: Nov 19, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
418
Actual
Start
Feb 27, 2023
Primary completion
Jun 2027
Study completion Jun 2031
Sponsor
- Lead sponsor
- Day One Biopharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- SIOPe Brain Tumor Group LOGGIC Consortium
- First posted
- Oct 4, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, up to 25 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a 2-arm, randomized, open-label, multicenter, global, Phase 3 trial to evaluate the efficacy, safety, and tolerability of tovorafenib monotherapy versus standard of care (SoC) chemotherapy in participants with pediatric low-grade glioma (LGG) harboring an activating rapidly accelerated fibrosarcoma (RAF) alteration requiring first-line systemic therapy.
Conditions
- Low-grade Glioma
- Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma
- Pediatric Low-grade Glioma
Interventions
TovorafenibDrug
Oral Tablet Powder for Oral Suspension
Chemotherapeutic AgentDrug
Intravenous solution for injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective response rate (ORR) of tovorafenib monotherapy versus SoC chemotherapyTime frame: Up to 60 months
Locations
138 sites in 30 countries. Site status is shown where the registry gives one.
Children's of Alabama
Birmingham, Alabama
Phoenix Children's Hospital
Phoenix, Arizona
Children's Hospital Los Angeles
Los Angeles, California
Children's Hospital of Orange County Main Campus - Orange
Orange, California
Packard Children's Hospital Stanford
Palo Alto, California
UCSF Benioff Children's Hospital
San Francisco, California
Children's Hospital Colorado
Aurora, Colorado
Connecticut Children's Medical Center
Hartford, Connecticut
Children's National Medical Center
Washington D.C., District of Columbia
University of Florida Health
Gainesville, Florida
Nicklaus Children's Hospital
Miami, Florida
Arnold Palmer Hospital for Children
Orlando, Florida
Johns Hopkins All Children's Hospital
St. Petersburg, Florida
Children's Healthcare of Atlanta
Atlanta, Georgia
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
University of Chicago
Chicago, Illinois
Riley Hospital for Children at Indiana University Health
Indianapolis, Indiana
University of Iowa Hospitals Clinics
Iowa City, Iowa
Norton Children's Hospital
Louisville, Kentucky
Maine Children's Cancer Program
Scarborough, Maine
Dana-Farber Cancer Institute
Boston, Massachusetts
University of Michigan - - C.S. Mott Children's Hospital
Ann Arbor, Michigan
Children's Minnesota
Minneapolis, Minnesota
Childrens MS Cncr Ctr Bld Dsr
Jackson, Mississippi
St. Louis Children's Hospital
St Louis, Missouri
University of Nebraska Medical Center
Omaha, Nebraska
Albany Medical Center
Albany, New York
New York University Langone Health
New York, New York
Columbia University
New York, New York
University of Rochester
Rochester, New York
Duke Cancer Institute
Durham, North Carolina
Cleveland Clinic Main Campus
Cleveland, Ohio
Oregon Health Science University
Portland, Oregon
Dell Children's Medical Center of Central Texas
Austin, Texas
University of Texas Southwestern Medical Center
Dallas, Texas
Texas Children's Hospital
Houston, Texas
Seattle Children's Hospital
Seattle, Washington
University of Wisconsin - Madison
Madison, Wisconsin
Perth Children's Hospital
Nedlands, Australia
Women's and Children's Health Network
North Adelaide, Australia
Showing 40 of 138 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.